• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Cosmetics
  • New cosmetic ingredients filed for China registration: 77 in total as of July 2023

New cosmetic ingredients filed for China registration: 77 in total as of July 2023

New cosmetic ingredients filed for China registration
Tuesday, 22 August 2023 / Published in Cosmetics, News, NMPA Registration in China

New cosmetic ingredients filed for China registration: 77 in total as of July 2023

New cosmetic ingredients filed for China registration have jumped to a total of 77 since the streamlined process has been implemented for cosmetic ingredients registration on May 1, 2021. In this blog post, we delve into the key developments and their implications for businesses.

Evolution of cosmetic ingredient registration

6 new cosmetic ingredients were registered in 2021 and 42 were registered in 2022. The trend persisted into 2023, with 29 new cosmetic ingredients filed as of July 26, 2023, indicating the trend of more streamlined approvals and requirements for new cosmetic ingredients approvals in China.

Read here for the list of new cosmetic ingredients filed for registration in China between January 2021 and July 2023.

Responsibilities during the monitoring period after market entry

During the monitoring period, which spans three years from the registration or filing of a new cosmetic ingredient, the responsible entity introducing the ingredient into the market is required to submit annual reports to the National Medical Products Administration (NMPA). These reports encompass the utilization of the new ingredient and its safety status. Should safety concerns arise with a new cosmetic raw material, the drug supervision and management department under the NMPA holds the authority to nullify the registration or record. Should a three-year period elapse without assurance of the safety of the new cosmetic ingredient, the NMPA and relevant management authorities compile a catalog of cosmetic ingredients in use.

Impact on industry players

The introduction of new regulations has significantly altered the landscape for cosmetic new raw material registration. Historically, the barriers were substantial—registration posed challenges in terms of difficulty, high costs, and protracted cycles. Moreover, there was a lack of a protection period for new raw material registrations, deterring potential entrants due to the absence of incentives. However, the recent legislative changes have ushered in a wave of benefits for industry participants.

Key regulatory shift: “Cosmetic new raw materials registration filing information management regulations”

On May 1, 2021, the National Medical Products Administration (NMPA) enacted the “Cosmetic New Raw Materials Registration Filing Information Management Regulations.” This announcement signified a pivotal turning point, streamlining the registration process for new cosmetic ingredients. By facilitating the filing of information and ushering in more transparency, these regulations have reduced the complexity of registration, alleviating the burden of difficulty and lengthy cycles.

Further information

Chinese cosmetics market is not only vast but also consistently expanding. In 2022, the market size reached an astounding USD $52.3 billion, with a compound annual growth rate (CAGR) of 9.2% over the past five years. This rapid growth indicates the untapped potential that awaits new entrants.

Entering the Chinese cosmetics market requires a keen understanding of the intricate regulatory landscape. Cisema specializes in deciphering ever-changing cosmetic ingredient regulations, and we are dedicated to helping clients adapt to these significant regulatory changes. Take a read to find out our service support for cosmetics and cosmetics ingredients in China, or should you need assistance navigating these regulatory changes, we are here to provide expert guidance tailored to your business needs.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

China Medical Device Standards
December 2021 Regulatory Roundup for Medical Device Mandatory Standards
Next Big Step for the Introduction of Hong Kong Medical Devices to the Greater Bay Area
Medical Device Master Files
Medical Device Master Files in China – clarification on use

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...
  • webinar_medical-device-market-authorisation

    Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

    Cisema is delighted to hold a Masterclass with ...
  • generative AI services

    China’s generative AI interim measures now in effect

    China’s generative AI interim measures fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP